Maturation of the Gag core decreases the stability of retroviral lipid membranes  by Davidoff, Candice et al.
Virology 433 (2012) 401–409Contents lists available at SciVerse ScienceDirectVirology0042-68
http://d
n Corr
E-mjournal homepage: www.elsevier.com/locate/yviroMaturation of the Gag core decreases the stability of
retroviral lipid membranesCandice Davidoff, Riley J. Payne, Sharon H. Willis, Benjamin J. Doranz, Joseph B. Rucker n
Integral Molecular, Inc. 3711 Market St, Suite 900, Philadelphia, PA 19104, United Statesa r t i c l e i n f o
Article history:
Received 23 April 2012
Returned to author for revisions
13 August 2012
Accepted 14 August 2012
Available online 17 September 2012
Keywords:
Virus-like particle
Detergent
Viral membrane
Maturation
Biosensor
Virus stability
Lipoparticle22/$ - see front matter & 2012 Elsevier Inc. A
x.doi.org/10.1016/j.virol.2012.08.023
esponding author. Fax: þ1 215 966 6136.
ail address: jrucker@integralmolecular.com (Ja b s t r a c t
To better understand how detergents disrupt enveloped viruses, we monitored the biophysical stability
of murine leukemia virus (MLV) virus-like particles (VLPs) against a panel of commonly used detergents
using real-time biosensor measurements. Although exposure to many detergents, such as Triton X-100
and Empigen, results in lysis of VLP membranes, VLPs appeared resistant to complete membrane lysis
by a signiﬁcant number of detergents, including Tween 20, Tween 80, Lubrol, and Saponin. VLPs
maintained their structural integrity after exposure to Tween 20 at concentrations up to 500-fold above
its CMC. Remarkably, VLPs containing immature cores composed of unprocessed (uncleaved) Gag
polyprotein were signiﬁcantly more resistant to detergent lysis than VLPs with mature cores. Although
the maturity of retroviral Gag is known to inﬂuence the stability of the protein core structure itself, our
studies suggest that the maturity of the Gag core also inﬂuences the stability of the lipid bilayer
surrounding the core.
& 2012 Elsevier Inc. All rights reserved.Introduction
Enveloped viruses are characterized by the encapsulation of
viral proteins and genetic elements by a lipid membrane acquired
directly from the host cell during viral budding. While some
enveloped viruses bud from cellular compartments such as the
endoplasmic reticulum (Mukhopadhyay et al., 2005) or the
nucleus (Mettenleiter et al., 2006), many, including murine leu-
kemia virus (MLV) and human immunodeﬁciency virus (HIV),
usually bud from the cellular plasmamembrane (Cadd et al., 1997;
Pelchen-Matthews et al., 2003; Pornillos et al., 2002; Sherer et al.,
2003). By directing the cellular location of budding, viral structural
proteins, such as the matrix component of the retrovirus Gag
polyprotein, help to determine the lipid composition of the viral
membrane (Ono et al., 2000; Spearman et al., 1997; Zhou and
Resh, 1996). Many enveloped viruses, including MLV and HIV,
are believed to selectively target sub-fragments of the plasma
membrane known as lipid rafts (or detergent-resistant mem-
branes, DRMs, as they are known when isolated) (Nguyen and
Hildreth, 2000; Ono and Freed, 2001; Pickl et al., 2001;
Suomalainen, 2002). Budding from lipid rafts enriches the mem-
branes of these viruses with cholesterol, sphingomyelin, andll rights reserved.
.B. Rucker).gangliosides (Aloia et al., 1988, 1993; Brugger et al., 2006), which
are known to stabilize lipid structures.
The lipid composition of viral membranes is a critical deter-
minant of viral stability and can inﬂuence the potential for viral
resilience and transmission (Aloia et al., 1988; 1993; Brugger
et al., 2006). Detergents are commonly employed for sanitizing
surfaces and ﬂuids against enveloped viruses, and previous
studies demonstrate the efﬁcacy of detergents against infectivity
of enveloped viruses (Horowitz et al., 1998; Oxford et al., 1971).
However, these types of studies commonly use detergent con-
centrations substantially above the detergent CMC and generally
are not focused on understanding their mechanism of inhibition.
On the basis of their disruptive activity in other membrane types,
it has largely been assumed that detergents act as lytic agents on
the viral membrane. However, the biophysical effects of different
detergents on viral lipid membrane structures have not been
directly investigated. The lack of such knowledge is signiﬁcant
given the common use of detergents in research and clinical
protocols. For example, many protocols used for blood products
employ Tween detergents to inactivate enveloped viruses
(Chernomordik et al., 1995; De Tkaczevski et al., 1968; Roberts,
2000; Seitz et al., 2002; Stromberg, 1972; Webster and Darlington,
1969). From a therapeutic perspective, viral membranes represent
potential targets for the activity of compounds that demonstrate
selective activity compared to host membranes, and two small
molecule compounds with preferential activity against membrane
enveloped viruses have been described (St Vincent et al., 2010;
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viral lipid membranes are well characterized, elucidating the bio-
physical properties of viral membrane structures may enable more
effective mechanisms of viral control and generate new insights into
mechanisms for selectively disrupting viral membranes.
To understand how detergents affect enveloped virions, we tested
a panel of commonly used detergents against murine leukemia virus
(MLV) virus-like particles (VLPs) using real-time (optical biosensor)
and conventional measurements of viral lipid membrane integrity.
Our results conﬁrm that exposure to many detergents results in lysis
of VLP membranes. However, MLV VLPs appeared highly resistant to
lysis by a number of other detergents, including those recommended
for clinical use. Most surprisingly, VLPs containing immature cores
composed of unprocessed (uncleaved) Gag polyprotein were sig-
niﬁcantly more resistant to detergent lysis than VLPs with mature
cores. The proﬁles of membrane lysis suggest that the core protein
structure determines whether the lipid bilayer is completely dis-
rupted and dissociates from Gag. Although the maturity of retroviral
Gag is known to inﬂuence the stability of the protein core structure
itself, our studies suggest that maturation of the Gag core also
decreases the stability of the lipid bilayer surrounding the core.Results
Detection of viral lipid membrane rupture by detergents
We previously showed that MLV virus-like particles (VLPs)
can be efﬁciently captured onto biosensor surfaces using anti-
bodies directed against receptors expressed on the surface
of virus membranes (Willis et al., 2008). Using this approach,Fig. 1. Detection of detergent-mediated rupture of viral membranes using an optical bi
speciﬁc capture antibodies. (B) Sample sensorgram for a complete biosensor VLP ruptu
resonance units (RU) on the biosensor chip surface. Upon titration with increasing con
detected when VLPs rupture and mass dissociates from the biosensor surface. Transie
injections. A sensorgram obtained for a control experiment in the absence of VLPs (gra
detergent injections. The biosensor chip is regenerated to the anti-mouse Fc covalentl
sensorgram trace is shown in greater detail to demonstrate the effect of increasing conc
absence of VLP binding is denoted by a dotted line. (D) To quantify the effect of detergen
concentration. RU values are baseline subtracted and expressed as a percent of total RU
with a vertical dotted line.we developed a real-time optical biosensor rupture assay on
captured VLPs exposed to a panel of detergents. The puriﬁed VLPs
used in these experiments are approximately 150 nm in diameter
in size and substantially free of contaminating cellular mem-
branes, as determined by peak measurements using dynamic light
scattering (Sup. Fig. 1). Puriﬁed MLV VLPs were efﬁciently
captured on a Biacore biosensor chip using an antibody (JS-81)
directed against the cell-surface protein CD81 (a schematic of the
capture event is depicted in Fig. 1A). CD81 is a member of the
tetraspanin family of proteins (containing four transmembrane
domains) and was chosen as a target for capture because it is
endogenously expressed in HEK-293 cells and is incorporated and
evenly distributed onto MLV VLP surfaces during production (at
least 16 copies of CD81 per virion) (Segura et al., 2008).
Since biosensor surface plasmon resonance (SPR, measured in
resonance units, RU) is directly proportional to the mass of
molecules on the chip surface (Canziani et al., 1999; Wang
et al., 2010) (within 200 nm distance from the chip surface),
the amount of VLPs remaining attached to the surface could be
directly monitored in real-time while increasing concentrations of
detergent were ﬂowed across (a complete experiment is depicted
in Fig. 1B). The constant ﬂow of detergent over the experimental
substrate represents a distinct advantage of this methodology
because the detergent concentration is maintained as a constant
throughout the experiment due to its continual renewal. In
comparison, traditional ﬁxed-volume detergent exposure experi-
ments (e.g. in cuvettes or wells) result in a reduction in free
detergent concentration upon detergent binding events, which
can be signiﬁcant in cases where low concentrations of detergent
are employed. A sensorgram obtained in the absence of VLPs
shows no change in baseline signal other than the transient spikesosensor. (A) Schematic representation of VLP association with a biosensor chip via
re experiment. Binding of capture antibody and VLPs results in increased optical
centrations of detergent for 15 s (Triton X-100 shown), decreases in VLP mass are
nt spikes in the sensorgram are due to refractive index changes upon detergent
y trace) shows no change in signal other than the transient spikes associated with
y coupled to the surface prior to re-use. (C) The detergent titration region of the
entrations of Triton X-100 on VLPs bound to the chip surface. Baseline signal in the
t on VLP membrane integrity, the biosensor signal (RU) is plotted against detergent
of captured VLPs in the absence of detergent. The CMC of Triton X-100 is indicated
C. Davidoff et al. / Virology 433 (2012) 401–409 403associated with detergent injections, demonstrating that the loss
of VLP mass is not the result of dissociation of the capture
antibody from the biosensor.
The critical micelle concentration (CMC) of a detergent is the
concentration of detergent where it begins forming micelles.
We therefore expected that at approximately the CMC of each
detergent, lipid-detergent micelles would begin forming, strip-
ping lipids out of the viral membrane and eventually causing
complete disruption of the lipid membrane and release of the
viral Gag proteins from the chip surface (a representative sensor-
gram is depicted in Fig. 1C). Thus, as expected, at approximately
the CMC of Triton X-100 (Fig. 1D, dashed vertical line), rupture of
the viral membrane and loss of the bulk of the virion mass was
observed as a dramatic decrease in surface plasmon resonance
RU. Nearly all of the virion mass was eliminated from the chip
within about a 10-fold concentration above the CMC, indicative
of complete rupture of the viral particles. Triton X-100 below
its CMC had little or no effect on viral structural integrity.
These results demonstrate that real-time measurement of mass
changes by optical biosensor can be used to detect viral membrane
rupture.
Resistance of VLP membrane rupture to several detergents
We next used the optical biosensor rupture assay to investi-
gate the effects of a panel of commonly used detergents on
mature VLP membrane stability. Triton X-100, b-octylglucoside
(BOG), CHAPS, NP-40, and Empigen all disrupted viral membranes
at concentrations close to their CMC, as expected for most
detergents interacting with lipid membranes (Helenius and
Simons, 1975; Schuck et al., 2003) (Fig. 2A–E). In contrast, we
were surprised to ﬁnd that other detergents, including Tween 20,
Tween 80, Lubrol, and saponin, caused minimal or no rupture of
VLPs, even at concentrations exceeding their CMC by 500-fold
(Fig. 2F–I). For example, VLPs maintained their structural integrity
after exposure to Tween 20, a detergent recommended for clinical
viral inactivation (Chernomordik et al., 1995; De Tkaczevski et al.,
1968; Roberts, 2000; Seitz et al., 2002; Stromberg, 1972; Webster
and Darlington, 1969), at concentrations up to 5%. To demonstrate
that VLP rupture was not dependent on the capture antibody or
protein tether used, we also tested VLPs containing the seven-
transmembrane GPCR CXCR4. Capture of CXCR4 VLPs using the
MAb 12G5, which recognizes a conformationally-sensitive epi-
tope on CXCR4 (Babcock et al., 2001; Endres et al., 1996), results
in nearly identical rupture proﬁles. The concentration at which
the initial loss of VLP mass was observed (its ‘rupture point’) was
quantiﬁed for each detergent (Table 1).
Uncleaved Gag stabilizes the viral lipid membrane
The MLV structural core is composed of the Gag polyprotein
and is associated with the internal leaﬂet of the lipid membrane
through the matrix (MA) component via N-terminal myristoyla-
tion. During viral maturation, MA is proteolytically cleaved from
the other subcomponents of Gag (e.g. capsid, nucleocapsid) by a
viral protease. Immature Gag proteins that do not undergo
proteolytic cleavage remain tethered to the inner viral membrane
as an intact polyprotein. Isolated immature Gag core structures
are known to be more resistant to detergents than mature cores
(Kol et al., 2006, 2007; Stewart et al., 1990). However, the lipid
bilayers surrounding immature and mature cores are biochemi-
cally identical so have largely been assumed to be structurally
identical and have similar detergent sensitivities.
To investigate whether maturity of the viral core affects lipid
membrane sensitivity to detergents, we produced MLV VLPs
containing an immature (uncleaved, pol deﬁcient) Gag structuralcore (‘Gag-His’, Fig. 2). Immature VLPs were attached to Biacore
biosensor chips and their structural integrity monitored during
detergent exposure. Surprisingly, the mass of immature VLPs
released from the biosensor surface upon exposure to most lytic
detergents was signiﬁcantly reduced compared to mature VLPs
(Fig. 2A–D). Similar rupture proﬁles were observed independent
of the capture antibody or protein tether used (i.e. JS-81 against
CD81 or 12G5 against CXCR4). Even very high concentrations of
Triton X-100 (up to 5%) failed to completely remove immature
VLPs from the chip surface. One exception to these results was
Empigen detergent treatment, which ruptured the membranes of
both mature and immature VLPs to an equal extent (Fig. 2E). Both
mature and immature VLPs were resistant to the non-lytic
detergents such as Tween 20, Tween 80, Lubrol, and saponin
(Fig. 2F–I). Identical sensitivities were obtained using VLPs engi-
neered to contain a different immature Gag polyprotein compris-
ing a fusion protein (Gag-GFP), demonstrating that these results
are not due to non-speciﬁc affects of the particular Gag construct
used. These results suggest that the retroviral lipid bilayer is less
susceptible to complete lysis and dissociation when surrounding
an unprocessed, immature viral core.
VLPs containing uncleaved Gag are stable with prolonged exposure
to Triton X-100
The stability of VLP membranes in the presence of several
detergents, even at concentrations known to eliminate viral
infectivity, was surprising. To test whether the resistance of VLPs
to certain detergents was due to insufﬁcient exposure time,
biosensor experiments were repeated for Tween 20 and Triton
X-100 using prolonged detergent exposure times. Our results
indicate that Tween 20 could dissociate virions from the surface
to a limited extent, but only for mature VLPs, at very high
concentrations (5% Tween 20 is 4700 fold above its CMC), and
in combination with prolonged exposure times (15 min under
continuous ﬂow conditions) (Fig. 3A). Even under these condi-
tions, however, the loss of signal from the biosensor surface
appeared gradual and unrelated to the CMC of Tween 20, unlike
the abrupt signal changes seen for lytic detergents such as Triton
X-100 upon crossing CMC thresholds. Importantly, prolonged
exposure of immature VLPs (Fig. 3B) to either Triton X-100 or
Tween 20 failed to remove any additional VLP mass from the
surface (unlike mature VLPs), consistent with the greater stability
of immature VLPs observed in response to diverse detergents. The
rupture point (concentration of ﬁrst loss of mass) upon exposure
to Triton X-100 remained identical between mature and imma-
ture VLPs regardless of the ﬂow time, suggesting that the forces
removing the VLPs at the detergent CMC (rupture) are different
than the forces dissociating the VLPs over time. These results
suggest that viral membranes surrounding immature Gag cores
are resistant to some detergents even with prolonged detergent
exposure times.
Immature Gag protein is selectively retained upon treatment of VLPs
with Triton X-100 detergent
While biosensor measurements provide valuable real-time
detection of mass changes, we wanted to conﬁrm these results
using an independent measure of viral membrane rupture. To do
this, we assayed for the presence of Gag protein by western blot
following treatment of VLPs with detergents (Fig. 4). Immature or
mature VLPs were captured onto an ELISA plate, treated with 1%
Tween 20, 1% Triton X-100, or 1% Empigen, and washed to remove
ruptured membranes and released Gag protein. The remaining
contents of each well were harvested, run on SDS-PAGE gels, and
assayed for retention of Gag protein (indicative of VLP stability in
Fig. 2. Resistance proﬁles of VLP membranes to a panel of diverse detergents. Mature VLPs (Gag-Pol, circles) and two different types of immature VLPs (Gag-His, triangles
and Gag-GFP, squares) were captured onto a Biacore C1 chip followed by treatment with increasing concentrations of the indicated detergents for 15 s. To control for the
use of capture antibody, VLPs were captured using an antibody against either endogenous CD81 (JS-81, ﬁlled symbols) or against the GPCR CXCR4 (12G5, open symbols).
Optical resonance signals were normalized to the maximum signal obtained using untreated VLPs. The CMC of each detergent is indicated with a vertical dotted line.
n¼3, representative plots from a single experiment are shown.
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polyclonal antibody. We found that immature VLPs washed with
Tween 20 or Triton X-100 retain uncleaved Gag protein atcomparable levels to mock treated VLPs (Fig. 4, left panel),
consistent with their greater stability observed by biosensor
measurements. In contrast, mature VLPs retained Gag proteins
Table 1
Critical micelle concentrations and VLP rupture points for detergents.
Detergent Class CMC Rupture point a
Triton X-100 Non-ionic 0.2–0.3 mM (0.0144% v/v) 0.02% v/v
b-octylglucoside (BOG) Non-ionic 14.5–25 mM 20 mM
CHAPS Zwitterionic 4–6 mM 8 mM
NP-40 Non-ionic 0.29 mM (0.016% v/v) 0.02% v/v
Empigen BB Zwitterionic 1.6–2.1 mM (0.04% v/v) 0.05–0.5% v/vb
Tween 20 Non-ionic 0.06 mM (0.007% v/v) No rupture
Tween 80 Non-ionic 0.012 mM (0.0015% v/v) No rupture
Lubrol Non-ionic 0.1 mM No rupture
Saponin Porator 0.05% w/v 0.05% w/v
a The experimental rupture point of mature VLPs is deﬁned by the concentration of
detergent that caused the ﬁrst loss of mass from the biosensor surface.
b The rupture point for Empigen is reported as a range to more accurately reﬂect its
actual rupture point. VLPs were exposed to 0.05% and 0.5% Empigen (a 10-fold range),
whereas the reported CMC of Empigen is 0.04% (Fig. 2E).
Fig. 3. Prolonged exposure of VLP membranes to Triton X-100 or Tween 20. (A) Mature or (B) immature VLPs were captured onto a Biacore biosensor chip and exposed to
increasing concentrations of Tween 20 or Triton X-100 up to 5% v/v. Detergents were ﬂowed over VLPs for a duration of 15 s, 1 min, 5 min, or 15 min to assess the effect of
prolonged detergent exposure time on VLP stability. The optical resonance signals were normalized to the maximum signal obtained using untreated VLPs. n¼3,
representative plots from a single experiment are shown.
Fig. 4. Gag retention in immature and mature VLPs following detergent treatment. Immature (Gag-GFP) and mature VLPs (Gag-Pol) were captured on a 96-well ELISA plate
using WGA lectin, followed by incubation with either Tween 20, Triton X-100, Empigen (all at 1%), or a no detergent control (mock). VLPs were washed three times, and the
remaining contents of each well were resuspended in SDS-PAGE loading buffer. Samples were run on a 4–20% SDS PAGE gradient gel, transferred to PVDF, and probed with
a Gag speciﬁc polyclonal antibody to assay for the amount of VLPs remaining in each well after detergent treatment. The Gag cleavage products capsid (CA) and matrix
(MA) are labeled. For immature VLPs, the Gag-GFP construct is observed as two bands: (1) Gag-GFP (the parental fusion protein) and (2) full length Gag (arising from
cleavage of Gag-GFP and consistent with previous observations using Gag fusion proteins) (Lindwasser and Resh, 2004). Experiment was performed twice with identical
results.
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of either type of VLP with Empigen resulted in complete disrup-
tion of VLP membranes and the absence of detectable Gag protein.
These results are consistent with the disruption proﬁles obtained
by biosensor and conﬁrm that mature VLPs show increased
sensitivity to disruption by Triton X-100.
Remarkably, we also observed that even in ‘mature’ VLPs, a
fraction of uncleaved Gag polyprotein was selectively retained
following exposure to Triton X-100, while the mature Gag proteinsubcomponents (Fig. 4, CA and MA) were washed away. The
presence of uncleaved Gag in mature VLP preparations is not
surprising, as both cleaved and uncleaved Gag proteins co-exist
within a population of ‘mature’ VLPs, with up to 30% immature
VLPs (Luftig and Yoshinaka, 1978; Yoshinaka et al., 1980). The
selective retention of uncleaved Gag over cleaved Gag is consis-
tent with the detergent resistance of immature VLPs, even when
coexisting within the larger population of mature VLPs. Interest-
ingly, both uncleaved and cleaved forms of Gag in the mature
C. Davidoff et al. / Virology 433 (2012) 401–409406VLPs were removed by Empigen detergent, consistent with the
ability of Empigen to remove all VLPs from the biosensor surface
(i.e. down to 0% signal in Fig. 2E). These results suggest that the
residual amount of VLPs remaining on the biosensor surface after
treatment of mature VLPs with Triton X-100 (i.e. down to 20–40%
signal in Fig. 2A) is likely due to VLPs containing immature Gag
within the larger population of mature VLPs. Maturation of the
Gag core protein thus explains the sensitivity of VLP membranes
to detergent in both assays and even within subpopulations of the
same VLP preparation.Discussion
Detergents are commonly employed in research and clinical
practice for sanitizing surfaces and ﬂuids against enveloped
viruses. On the basis of their disruptive activity in other mem-
brane types, it has largely been assumed that detergents act as
lytic agents on the viral membrane. However, the ability of
different detergents to rupture viral membranes has never before
been directly investigated. In this study, we demonstrate that
exposure to many detergents, including Triton X-100, BOG,
CHAPS, NP-40, and Empigen, at or near their CMC, results in
structural disruption of virion membranes. Remarkably, however,
VLP membranes appeared highly resistant to complete lysis
by a signiﬁcant number of detergents, including Tween 20, Tween
80, Lubrol, and saponin. Only at very high concentrations of
Tween 20 and with prolonged exposure was some gradual
rupture observed, and even then it did not appear related to the
CMC. Our results suggest that viral inactivation by detergents
likely involves complete lysis in some cases, but for other
detergents, likely involves other mechanisms such as localized
pore formation.
Unlike pure lipid bilayers, retroviral membranes interact with,
and are formed by, the structural proteins of the virus. In the case
of retroviruses, these structural proteins (Gag) have been well-
studied for their quaternary structure (Briggs et al., 2006a, 2006b;
Yeager et al., 1998; Zanetti et al., 2006), structural stability (Park
and Morrow, 1993; Stewart et al., 1990; Welker et al., 2000), and
membrane interactions (Dalton et al., 2007; Ono et al., 2000; Zhou
and Resh, 1996). Although it is known that isolated immature Gag
cores exhibit greater structural stability compared to mature Gag
cores (Kol et al., 2006, 2007; Stewart et al., 1990), there have been
no previous reports that Gag can inﬂuence the stability or
retention of the lipid bilayer surrounding the core. We were
therefore surprised to ﬁnd that VLPs containing immature
(unprocessed) core proteins were signiﬁcantly more resistant to
detergent lysis than VLPs with mature cores. A possible mechanism
for explaining how Gag processing inﬂuences detergent sensitiv-
ity is that immature Gag could be holding the entire virion
structure together more tightly, serving as a more rigid internal
scaffold to hold the lipid bilayer in place. This is supported by our
observation that the point of ﬁrst rupture is nearly identical for
mature and immature VLPs, suggesting that lytic detergents
initiate viral membrane rupture regardless of core structure but
that the maturity of the core structure determines whether the
lipid bilayer completely lyses and releases from the Gag core.
Alternatively, a more rigid, immature Gag core could directly
inﬂuence the ﬂuidity of the lipid membrane. This notion is
supported by atomic force microscopy studies showing that
immature HIV-1 virions are signiﬁcantly more ‘stiff’ than mature
particles (Kol et al., 2007). Maturation of the HIV-1 Gag core has
also been shown to affect the fusogenic ability of the Env glyco-
protein. In particular, the Env complex was shown to be non-
fusogenic in immature virions and becomes activated in mature
particles due to cytoplasmic tail proteolysis (Murakami et al., 2004).Taken together, these observations raise the intriguing possibi-
lity that Gag processing represents an important evolutionary
adaptation for enveloped viruses which helps promote their
survival, increasing the structural stability of nascent viral
particles and restricting their infectivity until proper release
from the host cell.
The loss of mass observed on the biosensor following treat-
ment of VLPs with detergent is interpreted here as membrane
rupture. Alternatively, the loss of mass could be interpreted as
a weakening of the antibody–antigen interaction by the deter-
gent leading to release of the VLPs from the biosensor surface.
However, we believe this scenario is highly unlikely for several
reasons. First, detergents such as Triton X-100 and Empigen are
well known to disrupt lipid membranes and the abrupt loss of
mass we observe occurs at or near the CMC of each detergent,
suggesting that mass loss is speciﬁcally due to micellization of the
VLP membranes. Second, we observe nearly identical mass losses
for detergent-treated VLPs using two different capture antibodies
against two very different membrane proteins (CD81 and CXCR4).
Finally, the shear forces on captured VLPs in a laminar ﬂow
environment are expected to be small and to not contribute to
particle detachment (Haun and Hammer, 2008).
Previous studies characterizing DRMs (lipid rafts) (Roper et al.,
2000; Schuck et al., 2003) provide important insights regarding
the detergent resistant properties of viral membranes. Both DRMs
and viral membranes contain high quantities of cholesterol,
sphingolipids, and saturated lipids that allow for the packing of
lipids at high densities (a liquid-ordered phase) (Aloia et al., 1988,
1993; Brown and Rose, 1992; Munro, 2003; Pike et al., 2002;
Polozov et al., 2008). A common characteristic of the detergents
that fail to rupture VLP membranes in our studies is a structurally
large polar head group, suggesting an inability of these detergents
to effectively penetrate these tightly-packed lipid bilayers, similar
to DRMs (de Foresta et al., 1989). It is important to note, however,
that DRMs and retroviral membranes are structurally different.
DRMs are often deﬁned by their method of detergent extraction in
the laboratory, so can possess different properties depending on
the methods used for their extraction (Babiychuk and Draeger,
2006; Chamberlain, 2004; Schuck et al., 2003). Retroviruses, by
contrast, are self-assembled by Gag without laboratory manip-
ulation, so they represent a model for isolating and studying
naturally occurring lipid domains in the cell membrane.
The response of mature VLPs to detergents revealed that lysis
did not usually progress to completion (i.e. intact mature VLPs did
not decrease to 0% except in the case of Empigen treatment).
This may be explained by the existence of a fraction of immature
VLPs even in populations of ‘mature’ VLPs. Our observation that
uncleaved Gag molecules are selectively retained during lysis of
mature VLPs (Fig. 4) supports this interpretation.
Non-enveloped viruses, such as rhinoviruses and adenoviruses,
maintain their structural stability during transmission in aerosols,
biological ﬂuids, and inhospitable environmental conditions
(Dick et al., 1987; Jennings and Dick, 1987; Roden et al., 1997;
Sene et al., 1995). In contrast, enveloped viruses are inherently
more fragile due to their lipid bilayer so may have evolved
mechanisms to maintain their stability during transmission
(Lowen et al., 2007; Polozov et al., 2008). To the extent that the
role of viral lipid membranes in viral stability and transmission
can be understood, characterizing them may reveal new avenues
for pharmaceutical intervention. Numerous antibiotics and lytic
peptides act against the unique composition of bacterial mem-
branes (Wimley and Hristova, 2011), yet few drugs have ever
been developed speciﬁcally against viral membranes, despite the
fact that they have unique biophysical properties required for
virus infectivity and resilience. The recent characterization of two
small molecule compounds that act directly on enveloped virus
C. Davidoff et al. / Virology 433 (2012) 401–409 407membranes illustrates that viral membranes represent viable
targets for drug development (St Vincent et al., 2010; Wolf
et al., 2010). From this perspective, differences in the biophysical
properties of structurally divergent enveloped viruses, such as
ﬂaviviruses, may be especially interesting to compare in future
studies. The detection assays developed here may be useful tools
for such studies, as well as for the study of other lytic agents
interacting with enveloped viruses. Our results suggest that the
development of microbicides and drugs that speciﬁcally target
the unique properties of the virus membrane represents a feasible
strategy for eliminating infective viral particles.Materials and methods
Materials
The following detergents were obtained commercially: Triton
X-100, Tween 20 (Fisher Scientiﬁc, Fair Lawn, NJ,), b-octylgluco-
side (BOG) (Sigma, St. Louis, MO), saponin, CHAPS, Lubrol
(MP Biomedicals, Solon, OH), NP-40 (Pierce, Rockford, IL), and
Empigen BB (Calbiochem, La Jolla, CA). The anti-CD81 (TAPA-1)
antibody, JS-81, was purchased from BD Biosciences (San Diego,
CA) and the 12G5 antibody, speciﬁc for the chemokine receptor
CXCR4, was obtained from Dr. James Hoxie at the University of
Pennsylvania. Anti-Gag polyclonal antibody was derived by
immunization of chickens with SDS-PAGE puriﬁed MLV Gag
(p70) (Cocalico Biologicals, Inc., Reamstown, PA).
VLP production, puriﬁcation, and characterization
Virus-like particles (VLPs) were produced using a plasmid
(pCGP) encoding the structural (gag) and non-structural (pol)
genes of MLV (Soneoka et al., 1995). Immature VLPs were
generated using a modiﬁed pCGP plasmid in which epitope or
ﬂuorescent tags were cloned as an in-frame fusion to the gag ORF
to eliminate the pol gene. To accomplish this, an NheI restriction
site was introduced after the gag gene using the QuickChange II
XL Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). pCGP
plasmids were used to transfect HEK-293T cells, and supernatants
containing VLPs were harvested and passed through a 0.45 mm
ﬁlter as previously described (Balliet and Bates, 1998; Hoffman
et al., 2000; Rucker, 2003). Filtered supernatants were puriﬁed
through 20% sucrose cushions and pellets were re-suspended in
10 mM HEPES pH 7.5 and stored at 4 1C. VLPs expressing CXCR4
(commercially referred to as ‘‘Lipoparticles’’) on their surface
were produced using similar methods, but by co-transfecting a
CXCR4 expression plasmid. Each lot of VLPs produced was
assayed for homogeneity by dynamic light scattering (DLS) using
a Proterion DynaPro DLS.
Biosensor stability studies
All biosensor surface attachments were performed in PBS
buffer alone or supplemented with 1 mg/ml BSA (running buffer)
at 25 1C using a Biacore 2000 optical biosensor (GE Healthcare,
Piscataway, NJ). VLPs were captured using monoclonal mouse
antibodies, either JS-81 (against CD81) or 12G5 (against CXCR4),
which were captured using a goat anti-mouse GAM Fc polyclonal
antibody (Jackson ImmunoResearch Westgrove, PA) immobilized
on the chip surface as previously described (Willis et al., 2008).
Brieﬂy, GAM Fc was diluted 1:10 in 0.1 M sodium acetate, pH
4.0 and attached to a Biacore C1 chip following a 10 min activa-
tion of surface carboxyl groups using a 1:1 mixture of 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)
(1 M) and N-hydroxysuccinimide (NHS) (0.25 M) at 10 ml/min.Following attachment, the remaining surface carboxyl groups
were quenched with 80 ml of 1 M ethanolamine, pH 8.5, at
10 ml/min. The capture antibody used was diluted to 5 mg/ml in
running buffer. About 20 ml of capture antibody was injected
at 10 ml/min, followed by 5 ml of VLPs at 1 ml/min. Detergent
solutions were made in running buffer and were introduced to
the system in six 5-ml injections of increasing concentration at
20 ml/min. Detergents were tested for 15 s (unless otherwise
indicated), with a 2-min wash between each injection. VLPs and
capture antibodies were removed following each stability experi-
ment using two 25-ml pulses of 1% Triton X-100 in PBS followed
by three 15-ml pulses of 100 mM H3PO4 at 50 ml/min. Data
analysis was performed using BiaEvaluation 3.0 (GE Healthcare,
Piscataway, NJ).
Western blot detection of disrupted VLPs
Mature and immature VLPs were captured onto 96-well ELISA
plates overnight at 4 1C using 10 mg/ml WGA lectin (Sigma, St
Louis, MO). VLPs were washed 3 with PBS and treated with 1%
Empigen, 1% Tween 20, or 1% Triton X-100 for 10 min at room
temperature with shaking. Following three PBS washes, the
contents of each well were lysed in 5 sample buffer (2 M Tris
HCl pH 6.8, 10% SDS, 20% glycerol, 0.005% bromophenol blue, and
50 mM DTT), boiled for 5 min, and loaded onto a 4–20% SDS-PAGE
gradient gel (NuSep, Bogart, GA). SDS-PAGE gels were run at
100 V for 1.5 h followed by transfer to PVDF membranes at 45 V
for 1.5 h at room temperature. Membranes were probed with a
polyclonal anti-Gag antibody (1:1000) followed by three washes
with PBS-T (PBSþ0.05% Tween). Blots were then incubated
with an HRP-conjugated secondary antibody, washed 3 with
PBS-T, followed by the addition of Femto HRP substrate (Pierce,
Rockford IL). Chemiluminescent detection was performed using a
Fluorchem imager (AlphaInnotech, now Protein Simple, Santa
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